Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells

Virology

Volumn 398, Issue 1, 2010, Pages 57-67

  Liu, Xiuying ^a   Wang, Tianyi ^b   Wakita, Takaji ^c   Yang, Wei ^a  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Acute infection in vitro; Hepatitis C virus; microRNA; mRNA; Systematic profiling

Indexed keywords

CHEMOKINE; CYTOKINE; MESSENGER RNA; MICRORNA; PROTEIN MIR 1181; PROTEIN MIR 149; PROTEIN MIR 24; PROTEIN MIR 638; UNCLASSIFIED DRUG; VIRUS RNA;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL METABOLISM; CONTROLLED STUDY; GENE CONSTRUCT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC DIFFERENCE; HEPATITIS C; HEPATOMA CELL; HOST CELL; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RNA ANALYSIS; SIGNAL TRANSDUCTION; VIRUS ENTRY; VIRUS REPLICATION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPACIVIRUS; HUMANS; LIVER NEOPLASMS; MICRORNAS; NEOPLASM PROTEINS; PROTEIN ARRAY ANALYSIS; RNA, MESSENGER; VIRUS INTERNALIZATION; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 75849132381     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.11.036     Document Type: Article

References (41)

1. Amemiya F., Maekawa S., Itakura Y., Kanayama A., Matsui A., Takano S., Yamaguchi T., Itakura J., Kitamura T., Inoue T., Sakamoto M., Yamauchi K., Okada S., Yamashita A., Sakamoto N., Itoh M., and Enomoto N. Targeting lipid metabolism in the treatment of hepatitis C virus infection. J. Infect. Dis. 197 (2008) 361-370
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
3. Bonci D., Coppola V., Musumeci M., Addario A., Giuffrida R., Memeo L., D'Urso L., Pagliuca A., Biffoni M., Labbaye C., Bartucci M., Muto G., Peschle C., and De Maria R. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat. Med. 14 (2008) 1271-1277
4. Cai Z., Zhang C., Chang K.S., Jiang J., Ahn B.C., Wakita T., Liang T.J., and Luo G. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J. Virol. 79 (2005) 13963-13973
5. Carraro G., El-Hashash A., Guidolin D., Tiozzo C., Turcatel G., Young B.M., De Langhe S.P., Bellusci S., Shi W., Parnigotto P.P., and Warburton D. miR-17 family of microRNAs controls FGF10-mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E-cadherin distribution. Dev. Biol. 333 (2009) 238-250
6. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., and Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 (1989) 359-362
7. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., Wojcik S.E., Aqeilan R.I., Zupo S., Dono M., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., and Croce C.M. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 13944-13949
8. Evans M.J., von Hahn T., Tscherne D.M., Syder A.J., Panis M., Wolk B., Hatziioannou T., McKeating J.A., Bieniasz P.D., and Rice C.M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446 (2007) 801-805
9. Guo C.J., Pan Q., Li D.G., Sun H., and Liu B.W. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J. Hepatol. 50 (2009) 766-778
10. Hon L.S., and Zhang Z. The roles of binding site arrangement and combinatorial targeting in microRNA repression of gene expression. Genome Biol. 8 (2007) R166
11. Johansson D.X., Voisset C., Tarr A.W., Aung M., Ball J.K., Dubuisson J., and Persson M.A. Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 16269-16274
12. Jopling C.L., Yi M., Lancaster A.M., Lemon S.M., and Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309 (2005) 1577-1581
13. Komurian-Pradel F., Paranhos-Baccala G., Sodoyer M., Chevallier P., Mandrand B., Lotteau V., and Andre P. Quantitation of HCV RNA using real-time PCR and fluorimetry. J. Virol. Methods 95 (2001) 111-119
14. Li Y., Tan W., Neo T.W., Aung M.O., Wasser S., Lim S.G., and Tan T.M. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci. 100 (2009) 1234-1242
15. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., and Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
16. Liu S., Yang W., Shen L., Turner J.R., Coyne C.B., and Wang T. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J. Virol. 83 (2009) 2011-2014
17. Marcucci G., Radmacher M.D., Maharry K., Mrozek K., Ruppert A.S., Paschka P., Vukosavljevic T., Whitman S.P., Baldus C.D., Langer C., Liu C.G., Carroll A.J., Powell B.L., Garzon R., Croce C.M., Kolitz J.E., Caligiuri M.A., Larson R.A., and Bloomfield C.D. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med. 358 (2008) 1919-1928
18. Marsit C.J., Eddy K., and Kelsey K.T. MicroRNA responses to cellular stress. Cancer Res. 66 (2006) 10843-10848
19. Martello G., Zacchigna L., Inui M., Montagner M., Adorno M., Mamidi A., Morsut L., Soligo S., Tran U., Dupont S., Cordenonsi M., Wessely O., and Piccolo S. MicroRNA control of Nodal signalling. Nature 449 (2007) 183-188
20. Murakami Y., Aly H.H., Tajima A., Inoue I., and Shimotohno K. Regulation of the hepatitis C virus genome replication by miR-199a. J. Hepatol. 50 (2009) 453-460
21. Nathans R., Chu C.Y., Serquina A.K., Lu C.C., Cao H., and Rana T.M. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol. Cell 34 (2009) 696-709
22. Park S.Y., Lee J.H., Ha M., Nam J.W., and Kim V.N. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat. Struct. Mol. Biol. 16 (2009) 23-29
23. Pedersen I.M., Cheng G., Wieland S., Volinia S., Croce C.M., Chisari F.V., and David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449 (2007) 919-922
24. Peng X., Li Y., Walters K.A., Rosenzweig E.R., Lederer S.L., Aicher L.D., Proll S., and Katze M.G. Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers. BMC Genomics 10 (2009) 373
25. Petrocca F., Vecchione A., and Croce C.M. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res. 68 (2008) 8191-8194
26. Raychaudhuri S., Fontanes V., Barat B., and Dasgupta A. Activation of ribosomal RNA transcription by hepatitis C virus involves upstream binding factor phosphorylation via induction of cyclin D1. Cancer Res. 69 (2009) 2057-2064
27. Rogler C.E., Levoci L., Ader T., Massimi A., Tchaikovskaya T., Norel R., and Rogler L.E. MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology 50 (2009) 575-584
28. Sarasin-Filipowicz M., Krol J., Markiewicz I., Heim M.H., and Filipowicz W. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat. Med. 15 (2009) 31-33
29. Shepard C.W., Finelli L., and Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5 (2005) 558-567
30. Timpe J.M., Stamataki Z., Jennings A., Hu K., Farquhar M.J., Harris H.J., Schwarz A., Desombere I., Roels G.L., Balfe P., and McKeating J.A. Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47 (2008) 17-24
31. Ura S., Honda M., Yamashita T., Ueda T., Takatori H., Nishino R., Sunakozaka H., Sakai Y., Horimoto K., and Kaneko S. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 49 (2009) 1098-1112
32. Uzri D., and Gehrke L. Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities. J. Virol. 83 (2009) 4174-4184
33. Varnholt H., Drebber U., Schulze F., Wedemeyer I., Schirmacher P., Dienes H.P., and Odenthal M. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 47 (2008) 1223-1232
34. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 (2005) 791-796
35. Walters K.A., Syder A.J., Lederer S.L., Diamond D.L., Paeper B., Rice C.M., and Katze M.G. Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes. PLoS Pathog. 5 (2009) e1000269
36. Wang H., Garzon R., Sun H., Ladner K.J., Singh R., Dahlman J., Cheng A., Hall B.M., Qualman S.J., Chandler D.S., Croce C.M., and Guttridge D.C. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14 (2008) 369-381
37. Yang W., Hood B.L., Chadwick S.L., Liu S., Watkins S.C., Luo G., Conrads T.P., and Wang T. Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production. Hepatology 48 (2008) 1396-1403
38. Yang W., Qiu C., Biswas N., Jin J., Watkins S.C., Montelaro R.C., Coyne C.B., and Wang T. Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus. J. Biol. Chem. 283 (2008) 8643-8653
39. Ye L., Wang X., Wang S., Wang Y., Song L., Hou W., Zhou L., Li H., and Ho W. CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes. Hepatology 49 (2009) 753-762
40. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., and Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 9294-9299
41. Zhu H., Dong H., Eksioglu E., Hemming A., Cao M., Crawford J.M., Nelson D.R., and Liu C. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. Gastroenterology 133 (2007) 1649-1659